Medication info

Poshu Tablet 10 mg (Dapagliflozin)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Dapagliflozin›10mg / 1 tablet
Manufacturer / importer
IYUN Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
100 tablets/bottle, 8 tablets/pouch [8 tablets/Alu-Alu]
Approval status
Approval withdrawn

MFDS item code 202004450 · Approved 2020.06.17

This product's status changed to Approval withdrawn on 2024.01.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
IYUN Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty controlling blood sugar
View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes. It can be administered alone along with diet and exercise therapy, or combined with other diabetes medications to enhance blood sugar control if necessary. It is particularly effective when used in conjunction with metformin, sulfonylureas, insulin, and sitagliptin. This drug can also be beneficial for patients who have difficulty controlling their blood sugar with existing treatments. It is used in various ways to improve blood sugar control.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with an allergy to the active ingredient or excipients. It must not be administered to patients with type 1 diabetes or those with diabetic ketoacidosis. Since it contains lactose anhydrous, it should not be given to patients with lactose intolerance or genetic related disorders. Patients undergoing dialysis should also avoid this medication. Patients with diminished fluid volume or impaired kidney function should exercise caution when using this drug. This medication can lower blood pressure or impact kidney function, so careful monitoring of fluid status and kidney function is critical. Elderly patients or those who are on diuretics may be at higher risk for hypotension and decreased fluid volume, so caution is warranted. The effectiveness of this drug on blood sugar control may vary depending on kidney function status. Infections of the genital area and urinary tract may occur while taking this medication, so proper hygiene should be maintained, and treatment should be sought immediately if infection symptoms arise. There is a risk of hypoglycemia, so dose adjustments may be necessary when used in conjunction with insulin or sulfonylureas. If symptoms of dehydration or hypotension appear, immediate consultation with medical personnel is required, and discontinuation of medication may be necessary. Diabetic ketoacidosis may occur, so prompt medical attention is required if symptoms such as vomiting, abdominal pain, or breathing difficulties present. This medication is not recommended for patients with severely impaired liver function. Women who are pregnant or breastfeeding should avoid using this medication. Safety and efficacy in pediatric patients have not been established. In cases of overdose, immediate medical intervention is necessary, and as there is no specific antidote, treatment should be symptomatic. Care should be taken while driving or operating machinery during the treatment, and one should be able to recognize and respond to symptoms of hypoglycemia. The medication should be stored in its original container, out of reach of children.

Side effects

  • Vulvovaginitis
  • balanitis
  • genitourinary infection
  • urinary tract infection
  • fungal infection
  • perineal necrosis
  • hypoglycemia
  • decreased body fluid volume
  • thirst
  • diabetic ketoacidosis
Show 151 more
  • dizziness
  • constipation
  • dry mouth
  • low back pain
  • pain during urination
  • polyuria
  • nocturia
  • interstitial nephritis
  • vulvar itching
  • genital itching
  • increased hematocrit
  • decreased renal creatinine clearance
  • dyslipidemia
  • increased blood creatinine
  • increased blood urea
  • weight loss
  • acute pyelonephritis
  • rash
  • hyperglycemia
  • paraesthesia
  • cerebral infarction
  • nerve compression
  • sinusitis
  • pneumonia
  • pulmonary tuberculosis
  • weakness
  • pain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • choledocholithiasis
  • cholangitis
  • alcoholic liver cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • anaphylactic reaction
  • chest pain
  • chest discomfort
  • fatigue
  • edema
  • foreign body sensation
  • facial swelling
  • facial pain
  • warmth
  • flu-like symptoms
  • menorrhagia
  • genital rash
  • irregular menstruation
  • hair loss
  • dermatitis
  • dry skin
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcer
  • hyperhidrosis eczema
  • nummular eczema
  • eczema
  • hyperkeratosis
  • nail pigmentation
  • skin lesions
  • urticaria
  • sweating
  • flank pain
  • fibromyalgia
  • limb discomfort
  • muscle cramps
  • musculoskeletal discomfort
  • osteoporosis
  • muscle weakness
  • contusion
  • drug toxicity
  • ankle fracture
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • hand fracture
  • ileal fracture
  • laceration
  • ligament rupture
  • limb injury
  • meniscal injury
  • skin abrasion
  • tendon rupture
  • thoracic vertebra fracture
  • tibial fracture
  • dental injury
  • dry eye
  • eye pain
  • retinal disorder
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid swelling
  • keratitis
  • ocular hypertension
  • visual impairment
  • vitreous floaters
  • oropharyngeal pain
  • allergic rhinitis
  • asthma
  • voice disorder
  • epistaxis
  • sleep apnea syndrome
  • wheezing
  • arteriosclerosis
  • flushing
  • peripheral coldness
  • varicose veins
  • vascular headache
  • orthostatic hypotension
  • atrial fibrillation
  • diastolic dysfunction
  • anxiety disorder
  • nocturia
  • auditory hallucinations
  • sleep disorders
  • insomnia
  • fatty liver
  • gallbladder polyp
  • dizziness
  • tinnitus
  • vaginal discharge
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • myalgia
  • osteoarthritis
  • ligament sprain
  • diabetic retinopathy
  • cough
  • dyspnea
  • palpitations
  • decreased appetite
  • thirst
  • taste disturbance
  • headache
  • sensory loss
  • nasopharyngitis
  • upper respiratory infection
  • hunger
  • vaginal discharge
  • itching

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is susceptible to the effects of air and moisture, so it should be stored in a sealed container. It is important to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. This will help to preserve the medication's effectiveness and safety over time.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

100 tablets/bottle, 8 tablets/pouch [8 tablets/Alu-Alu]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.